| Previous close | 0.0004 |
| Open | 0.0004 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0004 - 0.0004 |
| 52-week range | 0.0004 - 0.3600 |
| Volume | |
| Avg. volume | 123,254 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Safe signs a strategic partnership in the United States with a californian hospital group
Safe signs a strategic partnership in the United States with a californian hospital group Expansion of presence in the United States, the leading spine market Fleurieux-sur-l’Arbresle - France – May 13, 2024 at 6 p.m. Safe SA (la « Société ») announces the signing of a SAFE solutions referencing contract with a group of American hospitals based in California, bringing together 3,000 affiliated doctors, in around thirty outpatient centers and clinics as well as around a hundred doctors' offices t
- GlobeNewswire
SAFE - Bond financing agreement in a minimum amount of €850,000 to support the Group’s turnaround strategy
Bond financing agreement in a minimum amount of €850,000 to support the Group’s turnaround strategy Eragny-sur-Oise – France – March 11, 2024, 8.00 a.m. Safe SA (the “Company”) announces that it has arranged flexible bond financing with the Global Corporate Finance Opportunities 20 (GCFO 20) fund, a member of the Alpha Blue Ocean (ABO) group, through the issuance of warrants giving access to bonds convertible or exchangeable into new and/or existing shares with warrants attached in a minimum net
- GlobeNewswire
Court ruling in favor of Safe in its action against Neo Medical
Court ruling in favor of Safe in its action against Neo Medical Eragny-sur-Oise – France – February 5, 2024, 6pm CET. Safe SA (the “Company”) announces that on January 26, 2024, the Paris Judicial Court found in favor of Safe in its action against Neo Medical SA (Switzerland) and Neo Medical SASU (France) (Neo Medical). As a reminder, Safe took action against Neo Medical before the Paris Judicial Court for infringement of its French patent FR 2 990 840 (the “patent”), unfair unfair competition a
